ROCKWELL MEDICAL, INC. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-20: Form PRE 14A; Period of report 2026-04-20; Description PRE 14A; Document rmti-20260420.htm.
- 2022-03-21: Form PRE 14A; Period of report 2022-05-09; Description PRE 14A; Document tm229838d1_pre14a.htm.
- 2019-04-12: Form PRE 14A; Period of report 2019-06-06; Description PRE 14A; Document a19-2670_3pre14a.htm.
- 2018-04-13: Form PRE 14A; Period of report 2018-06-21; Description PRE 14A; Document a18-7093_3pre14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-20 | PRE 14A | 2026-04-20 | PRE 14A | rmti-20260420.htm |
| 2022-03-21 | PRE 14A | 2022-05-09 | PRE 14A | tm229838d1_pre14a.htm |
| 2019-04-12 | PRE 14A | 2019-06-06 | PRE 14A | a19-2670_3pre14a.htm |
| 2018-04-13 | PRE 14A | 2018-06-21 | PRE 14A | a18-7093_3pre14a.htm |
| 2013-03-19 | PRE 14A | 2013-04-30 | PRE 14A | a2213841zpre14a.htm |
| 2012-03-23 | PRE 14A | 2012-03-24 | PRELIMINARY PROXY STATEMENT | d287488dpre14a.htm |
| 2008-04-03 | PRE 14A | 2008-05-23 | PRELIMINARY PROXY STATEMENT | k25423ppre14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |